Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder
It is specifically characterized by inflammation, demyelination, and neuronal loss and manifests with a range of neurological symptoms including numbness, tingling, vision impairment, cognitive impairment, and bladder and bowel dysfunction (Tafti et al., 2024)
The Freeze-Thaw Fiasco: Re-freezing a reconstituted solution to 'make it last longer.' This is probably the most destructive single action you can take
Standard practice includes: Baseline thyroid function tests (TSH and free T4) before initiating GLP-1 therapy Repeat testing at 812 weeks after starting treatment or after dose escalation Regular monitoring every 36 months during active weight loss Return to annual monitoring once weight is stable and thyroid function remains consistent Adjustments to levothyroxine dosing may be necessary as weight changes
Ipamorelin is not a licensed medicine or drug and has not been approved by the MHRA, FDA, or any regulatory authority for human or veterinary use
reconstituted refrigerated and used within 30 days